Prion diseases

Clinics in Laboratory Medicine

Volumn 30, Issue 1, 2010, Pages 293-309

  Venneti, Sriram ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Creutzfeldt Jakob disease; Prion diseases; Rapidly progressive dementia; Transmissible spongiform encephalopathies

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; CHLORPROMAZINE; MEPACRINE; PENTOSAN POLYSULFATE;

AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BRAIN RADIOGRAPHY; CLINICAL FEATURE; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAPHY; ENDOCRINE DISEASE; HUMAN; IMMUNOASSAY; INFECTION SENSITIVITY; INTOXICATION; LABORATORY TEST; METABOLIC DISORDER; MICROBIOLOGY; MYCOSIS; NEOPLASM; NERVE DEGENERATION; NONHUMAN; PARASITOSIS; PATHOGENESIS; PRION; PRION DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYMPTOM; TREATMENT RESPONSE; VASCULAR DISEASE; VIRAL CONTAMINATION; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

DIAGNOSIS, DIFFERENTIAL; HUMANS; PRION DISEASES; PRIONS; PROGNOSIS;

EID: 77953340215     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2009.11.002     Document Type: Review

References (28)

1. Prusiner S.B. Shattuck lecture: neurodegenerative diseases and prions. N Engl J Med 2001, 344(20):1516-1526.
2. Mallucci G., Collinge J. Update on Creutzfeldt-Jakob disease. Curr Opin Neurol 2004, 17(6):641-647.
3. Liberski P.P., Brown P. Kuru: fifty years later. Neurol Neurochir Pol 2007, 41(6):548-556.
4. Sejvar J.J., Schonberger L.B., Belay E.D. Transmissible spongiform encephalopathies. J Am Vet Med Assoc 2008, 233(11):1705-1712.
5. Prusiner S.B. Prions. Proc Natl Acad Sci U S A 1998, 95(23):13363-13383.
6. Aguzzi A., Sigurdson C., Heikenwaelder M. Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 2008, 3:11-40.
7. Aguzzi A., Heikenwalder M., Polymenidou M. Insights into prion strains and neurotoxicity. Nat Rev Mol Cell Biol 2007, 8(7):552-561.
8. Aguzzi A., Baumann F., Bremer J. The prion's elusive reason for being. Annu Rev Neurosci 2008, 31:439-477.
9. Prusiner S.B. Prion diseases and the BSE crisis. Science 1997, 278(5336):245-251.
10. Aguzzi A., Glatzel M. Prion infections, blood and transfusions. Nat Clin Pract Neurol 2006, 2(6):321-329.
11. Johnson R.T. Prion diseases. Lancet Neurol 2005, 4(10):635-642.
12. Geschwind M.D., Haman A., Miller B.L. Rapidly progressive dementia. Neurol Clin 2007, 25(3):783-807. vii.
13. Geschwind M.D., Shu H., Haman A., et al. Rapidly progressive dementia. Ann Neurol 2008, 64(1):97-108.
14. Belay E.D., Schonberger L.B. Variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Clin Lab Med 2002, 22(4):849-862. v-vi.
15. Mead S., Poulter M., Uphill J., et al. Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study. Lancet Neurol 2009, 8(1):57-66.
16. Parchi P., Giese A., Capellari S., et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999, 46(2):224-233.
17. Aguzzi A., Sigurdson C.J. Antiprion immunotherapy: to suppress or to stimulate?. Nat Rev Immunol 2004, 4(9):725-736.
18. Harris D.A., True H.L. New insights into prion structure and toxicity. Neuron 2006, 50(3):353-357.
19. Prusiner S.B. The prion diseases. Brain Pathol 1998, 8(3):499-513.
20. DeArmond S.J., Prusiner S.B. Prion protein transgenes and the neuropathology in prion diseases. Brain Pathol 1995, 5(1):77-89.
21. Stewart L.A., Rydzewska L.H., Keogh G.F., et al. Systematic review of therapeutic interventions in human prion disease. Neurology 2008, 70(15):1272-1281.
22. Weissmann C., Aguzzi A. Approaches to therapy of prion diseases. Annu Rev Med 2005, 56:321-344.
23. DeArmond S.J., Prusiner S.B. Perspectives on prion biology, prion disease pathogenesis, and pharmacologic approaches to treatment. Clin Lab Med 2003, 23(1):1-41.
24. Mallucci G., Collinge J. Rational targeting for prion therapeutics. Nat Rev Neurosci 2005, 6(1):23-34.
25. Wadsworth J.D., Joiner S., Hill A.F., et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001, 358(9277):171-180.
26. Safar J.G., Geschwind M.D., Deering C., et al. Diagnosis of human prion disease. Proc Natl Acad Sci U S A 2005, 102(9):3501-3506.
27. Saborio G.P., Permanne B., Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001, 411(6839):810-813.
28. Aguzzi A. Prion biology: the quest for the test. Nat Methods 2007, 4(8):614-616.